Announcement under Regulation 30 (LODR)-Cessation
01-Apr-2026 | Source : BSEWe would like to inform you that Mr. Mukul Gupta (DIN: 00254597) Independent Director of the Company has completed his second and final term of 5 consecutive years as Independent Director on 31.03.2026 and accordingly he has ceased to be the Independent Director of the Company. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 3.01.2026 is enclosed herewith.
Announcement under Regulation 30 (LODR)-Change in Directorate
01-Apr-2026 | Source : BSEWe would like to inform you that Mr. Mukul Gupta (DIN: 00254597) Independent Director of the Company has completed his second and final term of 5 consecutive years as Independent Director on 31.03.2026 and accordingly he has ceased to be an Independent Director of the Company. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 is annexed herewith.
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
31-Mar-2026 | Source : BSEWe would like to inform you that the Company has received a Demand Order dated 30.03.2026 from the Office of the Joint Commissioner CGST Sub- Commissionerate Mohali Chandigarh under CGST / IGST Act 2017 raising a demand of Rs.22.88 Crore towards non-payment of GST including penalty thereon. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 and Industry Standards on Regulation 30 of SEBI LODR Regulations are enclosed herewith.
Corporate Actions
No Upcoming Board Meetings
Panacea Biotec Ltd has declared 75% dividend, ex-date: 19 Sep 11
No Splits history available
No Bonus history available
No Rights history available